Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) shares are trading lower Friday after the company announced a major regulatory win. read more

TQQQ leveraged ETF surged as investors cheered stronger-than-expected United States labor data. A broad rally in large-cap technology stocks directly fueled the fund’s sharp advance. read more

Ciena Corp (NYSE: CIEN) reported Q2 financial results, beating revenue estimates but missing EPS. Analysts have mixed ratings and lowered price targets. Latest Ratings for CIEN Date Firm Action From To Mar 2022 Raymond James Maintains Outperform Jan 2022 Raymond James Maintains Outperform Dec 2021 Needham Maintains Buy View More Analyst Ratings for CIEN View…

Shares of Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict molecular binding affinity with unmatched speed and accuracy. read more

Global economic uncertainty and trade tensions have sparked a shift towards high-dividend stocks, with companies like Realty Income and Enterprise Products Partners standing out for their consistent income and strong balance sheets. read more

Rocket Lab announced the launch window for its next mission, ‘The Mountain God Guards,’ for the Institute for Q-shu Pioneers of Space. read more

read more

Fartcoin (CRYPTO: FARTCOIN) has defied the broader market downturn with a 4% gain today, outperforming major meme coins like Dogecoin (CRYPTO: D read more

read more

read more